Rankings
▼
Calendar
BVS Q2 2021 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena
BVS
Bioventus Inc.
$593M
Q2 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$110M
+89.3% YoY
Gross Profit
$76M
69.5% margin
Operating Income
-$6M
-5.2% margin
Net Income
-$4M
-3.8% margin
EPS (Diluted)
$-0.10
QoQ Revenue Growth
+34.3%
Cash Flow
Operating Cash Flow
$17M
Free Cash Flow
$16M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$647M
Total Liabilities
$427M
Stockholders' Equity
$142M
Cash & Equivalents
$136M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$110M
$58M
+89.3%
Gross Profit
$76M
$40M
+89.1%
Operating Income
-$6M
-$5M
-25.0%
Net Income
-$4M
-$6M
+28.4%
Revenue Segments
Pain Treatments And Joint Preservation
$57M
52%
Restorative Therapies
$33M
30%
Bone Graft Substitutes
$21M
19%
Geographic Segments
UNITED STATES
$99M
90%
Non-US
$11M
10%
← FY 2021
All Quarters
Q3 2021 →